R Pg Family Wealth Advisory, LLC Regeneron Pharmaceuticals, Inc. Transaction History

R Pg Family Wealth Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$1024.09 - $1201.76 $168,974 - $198,290	165 Added 2.83%	5,991 $6.3 Million
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $18,547 - $22,494	-21 Reduced 0.36%	5,826 $6.12 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $71,312 - $78,474	79 Added 1.37%	5,847 $5.63 Million
Q4 2023 Jan 23, 2024	BUY	$775.18 - $881.7 $77,518 - $88,170	100 Added 1.76%	5,768 $5.07 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $3.92 Million - $4.79 Million	5,668 New	5,668 $4.66 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.